8,885 results on '"NASOPHARYNX cancer"'
Search Results
2. The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
- Author
-
Associazione Italiana Oncologia Cervico Cefalica, Ministry of Health, Italy, European Union, Alleanza Contro il Cancro, and Annalisa Trama, Head of the Epidemiology Valutative Unit
- Published
- 2024
3. 3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma
- Author
-
Jianguo Sun, Deputy director
- Published
- 2024
4. Combining Mefloquine with an Mcl-1 Inhibitor as a Novel Therapeutic Strategy for the Treatment of Nasopharyngeal Carcinoma.
- Author
-
Dong, Jiaqi, Zhang, Jianbin, Xiang, Gaojin, and Yang, Ling
- Subjects
- *
BIOLOGICAL models , *FLOW cytometry , *IN vitro studies , *T-test (Statistics) , *DATA analysis , *RESEARCH funding , *MEFLOQUINE , *ANTINEOPLASTIC agents , *APOPTOSIS , *CELL proliferation , *TREATMENT effectiveness , *OXIDATIVE stress , *XENOGRAFTS , *DESCRIPTIVE statistics , *IN vivo studies , *MICE , *CELL lines , *REACTIVE oxygen species , *DRUG repositioning , *ANIMAL experimentation , *WESTERN immunoblotting , *ONE-way analysis of variance , *STATISTICS , *NASOPHARYNX cancer , *COMPARATIVE studies , *SIGNAL peptides , *DRUG synergism , *MALONDIALDEHYDE , *PHARMACODYNAMICS , *CHEMICAL inhibitors - Abstract
Considering the established pharmacokinetics and toxicity profiles, drug repurposing has emerged as an alternative therapeutic approach for treating cancer. Mefloquine has previously demonstrated inhibitory effects on multiple cancer types. This study aims to explore the impact of mefloquine on nasopharyngeal carcinoma (NPC). We found that mefloquine, at pharmacologically achievable concentrations, displayed anti-NPC activity while sparing normal counterparts. Mefloquine inhibits proliferation and induces death by reducing the levels of Cyclin A2, Bcl-2, and Bcl-xL. Intriguingly, we observed an increase in the levels of the anti-apoptotic protein Mcl-1. Mefloquine exerts its effects on NPC cells by inducing lysosomal-mediated ROS production, and the heightened expression of Mcl-1 is a consequence of ROS generation in mefloquine-treated NPC cells. The combination of an Mcl-1 inhibitor with mefloquine synergistically inhibits NPC growth in mice without causing substantial toxicity. These findings demonstrate the effectiveness and limited toxicity of mefloquine as a monotherapy and in combination with an Mcl-1 inhibitor. Our research underscores the promise of the mefloquine and Mcl-1 inhibitor combination as a potential treatment for NPC. Additionally, the elevation of Mcl-1 is a compensatory response in cells exposed to oxidative stress, offering a potential target to overcome resistance induced by pro-oxidant therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Clinical performance of a prefabricated immunofluorescence assay for nasopharyngeal cancer screening.
- Author
-
Chen, Vanessa Hui En, Ong, Lizhen, Teo, Wei Keat, Siow, Chor Hiang, Goh, Han Lee, Tan, Charmaine, Lim, Wei Sian, Eu, Donovan, Cheong, Ian S. Y., Chan, Soh Ha, Loh, Kwok Seng, and Tay, Joshua K.
- Subjects
EARLY detection of cancer ,NASOPHARYNX cancer ,VIRAL antigens ,MEDICAL screening ,IMMUNOGLOBULIN A - Abstract
Background: Epstein–Barr virus (EBV) IgA serology for viral capsid antigen (VCA) and early antigen (EA) aids early detection of nasopharyngeal cancer (NPC), resulting in improved survival. We evaluated the diagnostic performance of a prefabricated immunofluorescent assay (IFA) for NPC screening in high‐risk individuals. Methods: Sera from 96 biopsy‐proven patients with NPC diagnosed at the outpatient clinic and 96 healthy family members were tested for EBV‐VCA IgA and EBV‐EA IgA using the prefabricated IFA from EUROIMMUN (EI) and the traditional immunofluorescence method. Results: The AUC of EI EBV‐VCA IgA and EBV‐EA IgA was 0.907 (95% confidence interval [CI]: 0.894–0.965) and 0.898 (95% CI: 0.848–0.947), respectively. Combined testing with the prefabricated assay at a threshold of VCA ≥1:320 or EA ≥1:10 showed 92.7% sensitivity and 81.2% specificity. Overall, the traditional EBV‐EA IgA assay demonstrated the best accuracy (sensitivity 91.7% and specificity 96.9%) at a threshold of ≥1:5. Conclusion: While the traditional IFA method was more accurate, the prefabricated IFA test kit can be a useful tool for NPC screening in high‐risk populations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Effects of tislelizumab on health‐related quality of life in patients with recurrent or metastatic nasopharyngeal cancer.
- Author
-
Yang, Yunpeng, Pan, Jianji, Chen, Nianyong, Guo, Ye, Huang, Xiaoming, Wu, Yanjie, Leaw, Shiangjiin, Bai, Fan, Wang, Yu, Zhao, Na, Tang, Boxiong, and Barnes, Gisoo
- Subjects
HEAD & neck cancer ,NASOPHARYNX cancer ,METASTASIS ,QUALITY of life ,CANCER chemotherapy - Abstract
Background: This study evaluated health‐related quality of life (HRQoL) in the RATIONALE‐309 (NCT03924986) intent‐to‐treat (ITT) population and in a subgroup of patients with liver metastases. Methods: Patients were randomized 1:1 to tislelizumab + chemotherapy or placebo + chemotherapy. As the secondary endpoint, HRQoL was evaluated using seven selected scores from the EORTC QLQ‐C30 and QLQ Head and Neck Cancer module (QLQ‐H&N35). Results: Of 263 randomized patients in the ITT population (tislelizumab + chemotherapy n = 131, placebo + chemotherapy n = 132), 43% had liver metastases (tislelizumab + chemotherapy n = 56; placebo + chemotherapy n = 57). No differences in change in selected scores on the QLQ‐C30 from baseline to cycle 4 or cycle 8 were observed for the ITT or liver metastases subgroup. No differences in selected QLQ‐H&N35 scores were observed between the arms from baseline to cycle 4. In the ITT population and the liver metastases subgroup, a greater reduction from baseline to cycle 8 was observed in the tislelizumab + chemotherapy arm than the placebo + chemotherapy arm in QLQ‐H&N35 pain score. At cycle 8 in the liver metastases subgroup, the tislelizumab + chemotherapy arm experienced greater improvement in the QLQ‐H&N35 senses problems score than the placebo + chemotherapy arm. Differences in time to deterioration between arms were not observed. Conclusions: The current findings, along with improved survival and favorable safety, suggests that tislelizumab + chemotherapy represents a potential first‐line treatment for recurrent or metastatic nasopharyngeal cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Tumor-associated macrophage-derived itaconic acid contributes to nasopharyngeal carcinoma progression by promoting immune escape via TET2.
- Author
-
Zhang, Xiaowei, Qian, Shen'er, Wu, Ping'an, Yu, Benquan, Yin, Danhui, Peng, Xia, Li, Shisheng, Xiao, Zian, and Xie, Zuozhong
- Subjects
- *
HEMATOPOIETIC stem cells , *NASOPHARYNX cancer , *ITACONIC acid , *IMMUNOSUPPRESSION , *T cells - Abstract
Nasopharyngeal carcinoma (NPC) is a malignant tumor of epithelial origin in head and neck with high incidence rate in South China, Southeast Asia and North Africa. The intervention of tumor-associated macrophages (Mφs) (TAMs)-mediated immunosuppression is a potential therapeutic strategy against tumor metastasis, but the exact mechanisms of TAM-mediated immunosuppression in nasopharyngeal carcinoma are unclear. Furthermore, how TAM affects the occurrence and development of nasopharyngeal carcinoma through metabolism is rarely involved. In this work, we revealed that NPC cells promoted M2-type Mφ polarization and elevated itaconic acid (ITA) release. Also, TAMs facilitated NPC cell proliferation, migration, and invasion through immune response gene 1 (IRG1)-catalyzed ITA production. Then, IRG1-mediated ITA production in TAMs repressed the killing of CD8+ T cells, induced M2-type polarization of TAMs, and reduced the phagocytosis of TAMs. Moreover, we demonstrated ITA played a tumor immunosuppressive role by binding and dampening ten-eleven translocation-2 (TET2) expression. Finally, we proved that ITA promotes NPC growth by facilitating immune escape in CD34+ hematopoietic stem cell humanized mice. In Conclusion, TAM-derived ITA facilitated NPC progression by enhancing immune escape through targeting TET2, highlighting that interfering with the metabolic pathway of ITA may be a potential strategy for NPC treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Deciphering the cellular landscape and potential targets of nasopharyngeal and oral cancers using single‐cell RNA sequencing.
- Author
-
Zhang, Yanfei, Qin, Xiaoyu, Lou, Weihua, Wang, Liang, Lu, Wuhao, Gao, Changhui, and Hu, Shousen
- Subjects
- *
ORAL cancer , *MAJOR histocompatibility complex , *NASOPHARYNX cancer , *RNA sequencing , *EPITHELIAL cells , *T cells - Abstract
Cellular heterogeneity in nasopharyngeal cancer (NPC) and oral cancer remains unclear. In the current study, using single‐cell RNA sequencing techniques, we investigated the cellular landscape in NPC and oral cancers. We identified a diverse range of cell types within the tumor microenvironment (TME) and variations in cell infiltration between NPC and oral cancer. In oral cancer, we observed a predominant infiltration of epithelial cells, fibroblasts, and endothelial cells (ECs), while T cells were the main infiltrating cell population in NPCs. We further classified these infiltrating cells into subclusters. Additionally, we observed complex interactions among cells that led to distinct trajectories. In particular, a unique epithelial subcluster with high expression of major histocompatibility complex class II (MHC‐II) molecules was correlated with a favorable outcome and infiltration of CD4+ T cells. In addition, MHC‐II+ epithelial cells inhibited mouse tumor growth and promoted T‐cell infiltration. Consequently, our findings provide a deep understanding of the TME showing a significant prognostic value and therapeutic potential. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Recent advances in early detection of nasopharyngeal carcinoma.
- Author
-
Jiang, Wen, Zheng, Bohao, and Wei, Hongquan
- Subjects
NASOPHARYNX cancer ,LANDSCAPE changes ,EARLY diagnosis ,NASOPHARYNX ,BIOMARKERS - Abstract
Nasopharyngeal carcinoma (NPC) arises from the mucosal epithelium of the nasopharynx and is frequently located in the pharyngeal crypts. This is a highly aggressive malignant tumor that frequently leads to distant metastases in many cases and poses a significant public health challenge, particularly in certain geographic regions globally. This review discusses the epidemiology, risk factors, diagnosis, and treatment options for NPC, emphasizing the importance of early detection and comprehensive management strategies in improving patient outcomes. Moreover, the article explores the intricate mechanisms that cause NPC. Comprehending these fundamental principles can assist in creating specific prevention and therapy approaches for NPC. Recent advances in diagnostic methods, including imaging tests and molecular biomarkers, are emphasized to improve early diagnosis and individualized treatment strategies for individuals with NPC. The review also explores the most recent advancements in treating early-stage (stage I and II) NPC patients, highlighting the changing landscape of individualized therapy approaches for this particular set of patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Peripheral hemoglobin to albumin ratio predicts prognosis in patients with nasopharyngeal carcinoma underwent concurrent chemoradiotherapy.
- Author
-
Zhang, Chao, Wang, Si-Fen, Zhang, Yu-Ling, and Teng, Cha-Xiang
- Subjects
- *
NASOPHARYNX cancer , *OVERALL survival , *RANKING (Statistics) , *REFERENCE values , *PROGNOSIS - Abstract
Background: Recently, the hemoglobin to albumin ratio (HAR) has been shown to be closely associated with the survival of certain malignancies. However, its prognostic value in nasopharyngeal carcinoma (NPC) remained to be elucidated. Herein, we aimed to explore the correlation between HAR and overall survival (OS) in NPC patients treated with concurrent chemoradiotherapy (CCRT). Methods: This retrospective study included a total of 858 patients with NPC receiving CCRT between January 2010 and December 2014 in Sun Yat-sen University Cancer Center. We randomly divided them into the training cohort (N = 602) and the validation cohort (N = 206). We performed univariate and multivariate Cox regression analyses to identify variables associated with OS, based on which, a predictive nomogram was constructed and assessed. Results: In both the training and validation cohorts, patients were classified into low- and high-HAR groups according to the cutoff value determined by the maximally selected rank statistics. This HAR cutoff value effectively divided patients into two distinct prognostic groups with significant differences. Multivariable Cox analysis revealed that higher T-stage, N-stage, and HAR values were significantly related to poorer prognosis in NPC patients and served as independent prognostic factors for NPC. Based on these, a predictive model was constructed and graphically presented as a nomogram, whose predictive performance is satisfactory with a C-index of 0.744 [95%CI: 0.679–0.809] and superior to traditional TNM staging system [C-index = 0.609, 95%CI: 0.448–0.770]. Conclusion: The HAR value was an independent predictor for NPC patients treated with CCRT, the predictive model based on HAR with superior predictive performance than traditional TNM staging system might improve individualized survival predictions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Proton pump inhibitors may increase the risk of cisplatin-induced acute kidney injury in patients with nasopharyngeal carcinoma: a prospective cohort study.
- Author
-
Luo, Haiqing, Yi, Guihua, Tang, Haifeng, Chen, Lingli, Hu, Liren, Yang, Donghong, Chen, Zihong, Li, Haiwen, Zhan, Dechao, Yu, Ying, Zeng, Ying, Cai, Yilin, Wu, Jiayuan, and Liu, Huafeng
- Subjects
- *
CISPLATIN , *ACUTE kidney failure , *PROTON pump inhibitors , *NASOPHARYNX cancer , *H2 receptor antagonists , *CHRONIC kidney failure , *COHORT analysis - Abstract
Cisplatin is the most commonly used platinum-based treatment for nasopharyngeal carcinoma (NPC). However, its clinical application is limited owing to its nephrotoxicity and gastrointestinal reactions. Proton pump inhibitors (PPIs) have been reported to increase nephrotoxicity risk in previous studies. We aimed to evaluate whether PPIs increase cisplatin-induced nephrotoxicity in patients with NPC. In total, 295 patients were included in this prospective cohort study: 145 in the PPIs group and 150 in the non-PPIs group. All patients underwent cisplatin-based induction chemotherapy, followed by cisplatin-based concurrent chemoradiotherapy. The PPIs group received 40 mg of intravenous esomeprazole sodium for 7 days in each chemotherapy cycle. Chi-squared test and logistic regression analyses with odds ratios and 95% confidence intervals were applied to assess the association between PPIs and the risk of acute kidney injury (AKI). AKI incidence in the PPIs group was significantly higher than that in the non-PPIs group (P = 0.005). After adjusting for various confounders including demographic features, clinical features, and renal function indices, PPIs use was significantly associated with a higher AKI risk (odds ratio: 2.775; 95% confidence interval 1.280–6.020; P = 0.010). The incidences of acute and chronic kidney diseases were similar between both groups (P > 0.05), whereas the incidence of nausea was lower in the PPIs group than in the non-PPIs group (P = 0.029). This study has shown that PPIs use may increase the risk of cisplatin-induced acute nephrotoxicity in patients with NPC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Effects of ambient temperature, relative humidity and absolute humidity on risk of nasopharyngeal carcinoma in China.
- Author
-
Di, Wenyi, Yu, Jiamin, Zong, Dan, Ge, Yizhi, Zhang, Yujie, Chen, Xin, and He, Xia
- Subjects
HUMIDITY ,NASOPHARYNX cancer ,TEMPERATURE effect ,LOW temperatures ,RURAL population - Abstract
Nasopharyngeal carcinoma (NPC) has a unique geographic distribution. It is unknown whether meteorological factors are related to the incidence of NPC. To investigate the effect of ambient temperature, relative humidity (RH), and absolute humidity (AH) on the incidence of NPC, we collected the incidence rate of NPC in 2016 and meteorological data from 2006 to 2016 from 484 cities and counties across 31 provinces in China. Generalized additive models with quasi‐Poisson regression and generalized linear models with natural cubic splines were employed respectively to elucidate the nonlinear relationships and specify the partial linear relationships. Subgroup and interactive analysis were also conducted. Temperature (R2 = 0.68, p <.001), RH (R2 = 0.47, p <.001), and AH (R2 = 0.70, p <.001) exhibited nonlinear correlations with NPC incidence rate. The risk of NPC incidence increased by 20.3% (95% confidence intervals [CI]: [18.9%, 21.7%]) per 1°C increase in temperature, by 6.3% (95% CI: [5.3%, 7.2%]) per 1% increase in RH, and by 32.2% (95% CI: [30.7%, 33.7%]) per 1 g/m3 increase in AH, between their the 25th and the 99th percentiles. In addition, the combination of low temperature and low RH was also related to increased risk (relative risk: 1.60, 95% CI: [1.18, 2.17]). Males and eastern or rural populations tended to be more vulnerable. In summary, this study suggests that ambient temperature, RH, and particularly AH are associated with the risk of NPC incidence. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Comparison of [18F]FDG and [68 Ga]pentixafor PET/CT in Nasopharyngeal Carcinoma.
- Author
-
Liu, Mengna, Chen, Xi, Ding, Haoyuan, Shu, Qiaoqiao, Zheng, Yun, Chen, Yue, and Cai, Liang
- Subjects
- *
NASOPHARYNX cancer , *POSITRON emission tomography , *COMPUTED tomography - Abstract
Purpose: This study aimed to explore the feasibility of [68 Ga]pentixafor positron emission tomography/computed tomography (PET/CT) in patients with nasopharyngeal carcinoma (NPC). Procedures: This prospective study included patients with NPC who underwent [68 Ga]pentixafor PET/CT and 2-[18F]fuoro-2-deoxy-D-glucose ([18F]FDG) PET/CT within one week between November 2022 and March 2023. The [68 Ga]pentixafor and [18F]FDG uptakes in primary and metastatic lesions were measured and compared. Results: Twenty-five participants (21 patients for initial stage and four patients for recurrence detection) were enrolled in our study. The participants underwent [18F]FDG PET/CT and [68 Ga]pentixafor PET/CT. [68 Ga]pentixafor PET/CT had the same detection rate as [18F]FDG for primary tumor (96% vs. 96%). The [68 Ga]pentixafor maximum standard uptake value (SUVmax) and target-to-background ratio (TBR) of primary tumors were lower than those of [18F]FDG (SUVmax: 8.13 ± 2.78 vs. 14.25 ± 6.45; P < 0.01; TBR: 5.17 ± 2.14 vs. 9.81 ± 5.30, P < 0.01). The difference between tumor volume of [68 Ga]pentixafor (TVpentixafor) and tumor volume of [18F]FDG (TVFDG) showed no significance (median: 16.01 vs. 9.56, P = 0.332). In the detection of suspected metastatic cervical lymph nodes (CLNs), [68 Ga]pentixafor PET possessed a lower SUVmax than [18F]FDG PET/CT (SUVmax: 6.86 ± 2.63 vs. 10.39 ± 5.28, P < 0.01), but there was no significant difference in the detection rate between [68 Ga]pentixafor and [18F]FDG PET/CT (96 vs. 98, P = 0.613). Conclusions: [68 Ga]pentixafor is a promising imaging tracer for detecting primary and metastatic NPC. [68 Ga]pentixafor PET/CT is comparable to [18F]FDG PET/CT in the detection rate of primary tumors and metastatic cervical lymph nodes in nasopharyngeal carcinoma, but [68 Ga]pentixafor uptake was heterogeneous. [68 Ga]pentixafor PET/CT may help select patients most likely to benefit from CXCR4-directed endoradiotherapy. Clinical trial registration No.: ChiCTR2200065902 [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma.
- Author
-
Lin, Da-Feng, Li, Hai-Lin, Liu, Ting, Lv, Xiao-Fei, Xie, Chuan-Miao, Ou, Xiao-Min, Guan, Jian, Zhang, Ye, Yan, Wen-Bin, He, Mei-Lin, Mao, Meng-Yuan, Zhao, Xun, Zhong, Lian-Zhen, Chen, Wen-Hui, Chen, Qiu-Yan, Mai, Hai-Qiang, Peng, Rou-Jun, Tian, Jie, Tang, Lin-Quan, and Dong, Di
- Subjects
- *
RECEIVER operating characteristic curves , *MAGNETIC resonance imaging , *NASOPHARYNX cancer , *OVERALL survival , *PROGNOSIS - Abstract
Background The prognostic value of traditional clinical indicators for locally recurrent nasopharyngeal carcinoma is limited because of their inability to reflect intratumor heterogeneity. We aimed to develop a radiomic signature to reveal tumor immune heterogeneity and predict survival in locally recurrent nasopharyngeal carcinoma. Methods This multicenter, retrospective study included 921 patients with locally recurrent nasopharyngeal carcinoma. A machine learning signature and nomogram based on pretreatment magnetic resonance imaging features were developed for predicting overall survival in a training cohort and validated in 2 independent cohorts. A clinical nomogram and an integrated nomogram were constructed for comparison. Nomogram performance was evaluated by concordance index and receiver operating characteristic curve analysis. Accordingly, patients were classified into risk groups. The biological characteristics and immune infiltration of the signature were explored by RNA-sequencing analysis. Results The machine learning signature and nomogram demonstrated comparable prognostic ability to a clinical nomogram, achieving concordance indexes of 0.729, 0.718, and 0.731 in the training, internal, and external validation cohorts, respectively. Integration of the signature and clinical variables statistically improved the predictive performance. The proposed signature effectively distinguished patients between risk groups with statistically distinct overall survival rates. Subgroup analysis indicated the recommendation of local salvage treatments for low-risk patients. Exploratory RNA-sequencing analysis revealed differences in interferon response and lymphocyte infiltration between risk groups. Conclusions A magnetic resonance imaging–based radiomic signature predicted overall survival more accurately. The proposed signature associated with tumor immune heterogeneity may serve as a valuable tool to facilitate prognostic stratification and guide individualized management for locally recurrent nasopharyngeal carcinoma patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Failure patterns and individualized treatment plans of reirradiation for inoperable locally recurrent nasopharyngeal carcinoma.
- Author
-
Lin, Cheng, Lu, Qiongjiao, Chen, Yuebing, Chen, Xiaoqiang, Huang, Yiping, Zhong, Hangyan, Peng, Xiane, Hu, Cairong, Chen, Bijuan, Lin, Shaojun, and Zong, Jingfeng
- Subjects
- *
STATISTICAL correlation , *NASOPHARYNX cancer , *INTENSITY modulated radiotherapy , *OVERALL survival , *RADIOTHERAPY - Abstract
Re-irradiation with intensity-modulated radiotherapy (IMRT) remains the primary treatment modality for inoperable locally recurrent nasopharyngeal carcinoma (NPC). However, the rate of radiation-related late adverse effects is often substantially high. Therefore, we aimed to explore failure patterns and individualized treatment plans of re-irradiation for inoperable locally recurrent NPC. Ninety-seven patients who underwent IMRT were retrospectively analyzed. Sixty-two patients had clinical target volume of recurrence (rCTV) delineated, and thirty-five patients had only gross tumor volume of recurrence (rGTV) delineated. Twenty-nine patients developed second local failures after re-irradiation with IMRT (28 cases available). Among those patients, 64.3% (18/28) of patients and 35.7% (10/28) developed in-field or out-field, respectively. No statistical correlation was observed between target volume (rGTV or rCTV) and the local recurrence rate, local failure patterns, grade ≥ 3 toxicity, and survival. Multivariate analysis showed that recurrent T (rT) stage (HR 2.62, P = 0.019) and rGTV volume (HR 1.73, P = 0.037) were independent prognostic factors for overall survival (OS). Risk stratification based on rT stage and rGTV volume revealed that low risk group had a longer 3-year OS rate (66.7% vs. 23.4%), lower total grade ≥ 3 toxicity (P = 0.004), and lower re-radiation associated mortality rates (HR 0.45, P = 0.03) than high risk group. This study demonstrates that the delineation of rCTV may not be beneficial for re-irradiation using IMRT in locally recurrent NPC. Patients with low risk were most suitable for re-irradiation, with maximizing local salvage and minimizing radiation-related toxicities. More precise and individualized plans of re-irradiation are warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Effects of psychological support intervention on patients with nasopharyngeal carcinoma undergoing radiotherapy.
- Author
-
Ce Wang, Xiaohui Liu, Yanhong Li, Dongxue Liu, Litao Yang, and Yue Wang
- Subjects
- *
PSYCHOTHERAPY , *NASOPHARYNX cancer , *RADIOTHERAPY , *UNIVERSITY hospitals , *CANCER radiotherapy , *QUALITY of life , *CONTROL groups , *PSYCHOLOGICAL resilience - Abstract
Objective: To find out the effects of psychological support intervention on patients with nasopharyngeal carcinoma undergoing radiotherapy. Methods: This was a retrospective study. Sixty six patients with nasopharyngeal carcinoma who received radiotherapy in the Affiliated Hospital of Hebei University from March 2021 to March 2022 were included and randomly divided into the observation group and the control group, with 33 cases in each group. Patients in the control group were given conventional care measures, while those in the observation group were given psychological support intervention on top of conventional care measures. The nursing effects between the two groups were compared. Results: After the intervention, the psychological resilience score of the observation group was significantly higher than that of the control group, with a statistically significant difference (P<0.05). The psychological resilience scores after the intervention were significantly higher in the observation group than before the intervention, and those in the control group were higher than before the intervention, with a statistically significant difference(P<0.05). The overall health score of quality of life in the observation group was significantly higher than that in the control group after the intervention, with a statistically significant difference(P<0.05). Moreover, the skin reaction in the observation group after radiotherapy was significantly better than that of the control group (P<0.01). Conclusion: Psychological support intervention is an effective means to treat patients with nasopharyngeal carcinoma, which results in various benefits such as improving patients’ mental resilience and quality of life and reducing the incidence of adverse reactions after radiotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Prospective evaluation of the relevance of Epstein–Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adults.
- Author
-
Yang, Ling, Kartsonaki, Christiana, Simon, Julia, Yao, Pang, Guo, Yu, Lv, Jun, Walters, Robin G, Chen, Yiping, Fry, Hannah, Avery, Daniel, Yu, Canqing, Jin, Jianrong, Mentzer, Alexander J, Allen, Naomi, Butt, Julia, Hill, Michael, Li, Liming, Millwood, Iona Y, Waterboer, Tim, and Chen, Zhengming
- Subjects
- *
VIRAL antibodies , *IMMUNOGLOBULIN A , *NASOPHARYNX cancer , *IMMUNOGLOBULIN G , *SEROLOGY - Abstract
Background Epstein–Barr virus (EBV) is a major cause of nasopharyngeal carcinoma (NPC) and measurement of different EBV antibodies in blood may improve early detection of NPC. Prospective studies can help assess the roles of different EBV antibodies in predicting NPC risk over time. Methods A case-cohort study within the prospective China Kadoorie Biobank of 512 715 adults from 10 (including two NPC endemic) areas included 295 incident NPC cases and 745 subcohort participants. A multiplex serology assay was used to quantify IgA and IgG antibodies against 16 EBV antigens in stored baseline plasma samples. Cox regression was used to estimate adjusted hazard ratios (HRs) for NPC and C-statistics to assess the discriminatory ability of EBV-markers, including two previously identified EBV-marker combinations, for predicting NPC. Results Sero-positivity for 15 out of 16 EBV-markers was significantly associated with higher NPC risk. Both IgA and IgG antibodies against the same three EBV-markers showed the most extreme HRs, i.e. BGLF2 (IgA: 124.2 (95% CI: 63.3–243.9); IgG: 8.6 (5.5–13.5); LF2: [67.8 (30.0–153.1), 10.9 (7.2–16.4)]); and BFRF1: 26.1 (10.1–67.5), 6.1 (2.7–13.6). Use of a two-marker (i.e. LF2/BGLF2 IgG) and a four-marker (i.e. LF2/BGLF2 IgG and LF2/EA-D IgA) combinations yielded C-statistics of 0.85 and 0.84, respectively, which persisted for at least 5 years after sample collection in both endemic and non-endemic areas. Conclusions In Chinese adults, plasma EBV markers strongly predict NPC occurrence many years before clinical diagnosis. LF2 and BGLF2 IgG could identify NPC high-risk individuals to improve NPC early detection in community and clinical settings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Capsaicin enhances cisplatin-induced anti-metastasis of nasopharyngeal carcinoma by inhibiting EMT and ERK signaling via serpin family B member 2.
- Author
-
Xu, Yafei, Kong, Weimiao, Zhao, Simin, Xiong, Dan, and Wang, Yejun
- Subjects
- *
SQUAMOUS cell carcinoma , *GENE expression , *NASOPHARYNX cancer , *ANTINEOPLASTIC agents , *PROTEIN expression , *HEAD & neck cancer , *CETUXIMAB - Abstract
Cisplatin (DDP)-based combined chemotherapy or concurrent chemoradiotherapy is the mainstay treatment for advanced-stage nasopharyngeal carcinoma (NPC), but needs improvement due to its severe side effects. Capsaicin (CAP) can enhance the anti-tumor activity of cytotoxic drugs. The aim of this study was to investigate the anti-metastasis activity of CAP in combination with DDP in NPC. Herein, CAP and DDP showed synergistic cytotoxic effects on NPC cells. CAP alone and DDP alone inhibited NPC migration and invasion in vitro and in vivo , and the combination of CAP and DDP had the greatest effect. Moreover, CAP upregulated the mRNA and protein expressions of serpin family B member 2 (SERPINB2). Further results showed that both SERPINB2 mRNA and protein expressions were downregulated in NPC cell lines and tissues and SERPINB2 overexpression inhibited NPC migration and invasion in vitro and in vivo , while silencing SERPINB2 acted oppositely. In addition, SERPINB2 was abnormally expressed in head and neck squamous cell carcinoma and other multiple cancers, and downregulation of SERPINB2 predicted poor prognosis in head and neck squamous cell carcinoma according to the Cancer Genome Atlas database. We further found that SERPINB2 overexpression inhibited epithelial–mesenchymal transition (EMT) and the phosphorylated extracellular signal-regulated kinase (p-ERK), and the inhibitory effect was enhanced by CAP and DDP. Altogether, our results suggest that the combined inhibition of CAP and DDP on NPC metastasis may be related to the inhibition of epithelial–mesenchymal transition and ERK signals mediated by SERPINB2, and CAP may help to improve the efficacy of DDP in the treatment of NPC and develop new therapeutic approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Serum inflammatory markers as prognostic marker for nasopharyngeal carcinoma with liver metastasis: a multi-center retrospective study.
- Author
-
Saboorifar, Hossein, Zafarani, Yasamin, Gholampour, Golsa, Roghani, Arman, Qiu, Feng, Dequaniter, Dideir, and Yu, Qiao
- Subjects
- *
LIVER metastasis , *BIOMARKERS , *NASOPHARYNX cancer , *PROGNOSIS , *NEUTROPHIL lymphocyte ratio ,NASOPHARYNX tumors - Abstract
Background: This retrospective study investigated the prognostic value of serum inflammatory markers in nasopharyngeal carcinoma (NPC) patients, focusing on their association with overall survival (OS) and liver metastasis-free survival (LMFS). Methods: The study included 314 NPC patients treated between 2010 and 2020. Clinical characteristics, treatment methods, and serum inflammatory markers were assessed. Patients were categorized into two groups of with and without liver metastasis. Univariate and multivariate Cox regression and Kaplan–Meier survival analyses were performed to investigate the prognostic value of serum inflammatory markers in NPC patients with and without liver metastasis. Results: In the whole cohort, univariate Cox regression analysis singled out tumor necrosis factor-α (TNF-α) (HR = 1.57, 95% CI 1.44–4.90, p = 0.004) and neutrophil-to-lymphocyte ratio (NLR) (HR = 2.13, 95% CI 1.33–3.99, p = 0.009), which were significantly associated with poorer OS. In patients with liver metastasis, TNF-α and NLR could not independently predict OS. However, high TNF-α levels were independently associated with worse OS in patients without liver metastasis (HR (95% CI) = 2.75 (1.67–8.68), p < 0.001). High NLR levels could independently predict poor OS in both groups with (HR (95% CI) = 1.94 (1.77–6.38), p = 0.010) and without liver metastasis (HR (95% CI) = 1.58 (1.19–7.54), p = 0.009). Ultimately, TNF-α and NLR could not significantly predict LMFS. Conclusion: This study highlights the prognostic significance of TNF-α and NLR in NPC patients, especially in those with liver metastasis. These inflammatory markers could serve as valuable indicators for assessing the prognosis of NPC patients. Further research is warranted to validate their clinical utility and explore potential therapeutic implications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Anti-angiogenesis agents plus chemoradiotherapy for locally advanced nasopharyngeal cancer: a systematic review and meta-analysis.
- Author
-
Sun, Xueqing, Zhu, Youqi, Lou, Yufei, Lu, Xinyu, Wang, Bo, Yu, Dehong, Guo, Yilong, and Xin, Yong
- Subjects
- *
NASOPHARYNX cancer , *CHEMORADIOTHERAPY , *NEOVASCULARIZATION inhibitors , *ARRHYTHMIA ,NASOPHARYNX tumors - Abstract
Purpose: To evaluate literature evidences about the efficacy and safety of anti-angiogenesis agents plus chemoradiotherapy versus chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma. Methods: The relevant literature was systematically searched from the date of establishment to April 2023 in PubMed, Embase, Web of Science, The Cochrane Library, Chinese National Knowledge Infrastructure, Chinese Biological Medicine, Wanfang and VIP database. Search terms included: Nasopharyngeal Neoplasms, Angiogenesis inhibitors, Endostar, Anlotinib, Apatinib, Bevacizumab, Sunitinib, Pazopanib, Chemoradiotherapy. The literature was strictly screened according to the inclusion and exclusion criteria, and 8 eligible studies were finally included in our meta-analysis (4 randomized controlled trials and 4 retrospective studies). Results: A total of 642 patients were included, with 316 in the anti-angiogenesis agents plus chemoradiotherapy group and 326 in the chemoradiotherapy group. The results of our meta-analysis showed that compared with chemoradiotherapy group, the complete response rate (RR = 1.35, 95% CI 1.05–1.74, P = 0.02), objective response rate (RR = 1.26, 95% CI 1.12–1.43, P = 0.0002) in the anti-angiogenesis agents plus chemoradiotherapy group were significantly improved. In terms of safety, there was a higher incidence of cardiac arrhythmia (RR = 3.63, 95% CI 1.16–11.37, P = 0.03) and hypertension (RR = 1.85, 95% CI 1.04–3.27, P = 0.004) in the anti-angiogenesis agents plus chemoradiotherapy group, while no statistically significant differences were reported in other adverse reactions (all P > 0.05). Conclusion: Compared with chemoradiotherapy, anti-angiogenesis agents plus chemoradiotherapy could bring more benefits in terms of short-term efficacy, particularly by notably improving both complete response rate and objective response rate, and overall adverse reactions were acceptable. Anti-angiogenesis agents plus chemoradiotherapy may provide a promising direction for the treatment of locally advanced nasopharyngeal carcinoma. Systematic Review Registration: https://inplasy.com/inplasy-2023-8-0076/, registration number INPLASY202380076. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Malignant Transformation of Juvenile Nasopharyngeal Angiofibroma in a Non-irradiated Case: A Rarity Denuded.
- Author
-
Narayanan, Janakiram Trichy, Sampath, Soumya, Venktaramanan, Mansi A. R., G., Arunkumar, and Rath, Pradipta Kumar
- Subjects
NASOPHARYNX cancer ,INTENSITY modulated radiotherapy ,IRRADIATION ,HISTOPATHOLOGY ,SURGICAL excision - Abstract
Nasopharyngeal angiofibroma is a relatively rare tumor, which is locally aggressive and histologically benign with transformation to a malignant sarcomatous form in a previously irradiated candidate. Here we are reporting the second known case according to literature of a non irradiated case of nasopharyngeal angiofibroma who was previously operated 11 times for the excision of nasopharyngeal angiofibroma. All the previous biopsy reports were proven to be of nasopharyngeal angiofibroma, but for the last time, when he was operated at our center, biopsy showed malignant transformation of nasopharyngeal angiofibroma. The patient was then subjected to intensity modulated radiotherapy and is in close surveillance, doing well till date. Hence this case presentation gives an insight about malignant transformation of nasopharyngeal angiofibroma in absence of irradiation, which is a very rare entity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Isoliquiritigenin diminishes invasiveness of human nasopharyngeal carcinoma cells associating with inhibition of MMP‐2 expression and STAT3 signalling.
- Author
-
Lu, Yen‐Ting, Hsin, Chung‐Han, Kao, Shao‐Hsuan, Ho, Yu‐Ting, Yeh, Fang‐Ling, Yang, Shun‐Fa, and Lin, Chiao‐Wen
- Subjects
CELLULAR signal transduction ,NASOPHARYNX cancer ,PROTEIN expression ,WESTERN immunoblotting ,GENETIC transcription - Abstract
Nasopharyngeal carcinoma (NPC) is prevalent in Asia and exhibits highly metastatic characteristics, leading to uncontrolled disease progression. Isoliquiritigenin (ISL) have attracted attention due to their diverse biological and pharmacological properties, including anticancer activities. However, the impact of ISL on the invasive and migratory ability of NPC remains poorly understood. Hence, this study aimed to investigate the in vitro anti‐metastatic effects of ISL on NPC cells and elucidate the underlying signalling pathways. Human NPC cell NPC‐39 and NPC‐BM were utilized as cell models. Migratory and invasive capabilities were evaluated through wound healing and invasion assays, respectively. Gelatin zymography was employed to demonstrate matrix metalloproteinase‐2 (MMP‐2) activity, while western blotting was conducted to analyse protein expression levels and explore signalling cascades. Overexpression of signal transducer and activator of transcription 3 (STAT3) was carried out by transduction of STAT3‐expressing vector. Our findings revealed that ISL effectively suppressed the migration and invasion of NPC cells. Gelatin zymography and Western blotting assays demonstrated that ISL treatment led to a reduction in MMP‐2 enzyme activity and protein expression. Investigation of signalling cascades revealed that ISL treatment resulted in the inhibition of STAT3 phosphorylation. Moreover, overexpression of STAT3 restored the migratory ability of NPC cells in the presence of ISL. Collectively, these findings indicate that ISL inhibits the migration and invasion of NPC cells associating with MMP‐2 downregulation through suppressing STAT3 activation. This suggests that ISL has an anti‐metastatic effect on NPC cells and has potential therapeutic benefit for NPC treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Comorbidity profiling identifies potential subtype of elderly patients with nasopharyngeal carcinoma.
- Author
-
Li, Ying, Pan, Yuhui, Huang, Zongwei, Wu, Lishui, Wu, Wenxi, Xu, Siqi, Chen, Zihan, Chen, Xin, Lu, Jun, and Qiu, Sufang
- Subjects
MORTALITY risk factors ,RISK assessment ,METABOLIC disorders ,SURVIVAL rate ,PREDICTION models ,RESEARCH funding ,CANCER relapse ,STRUCTURAL equation modeling ,DESCRIPTIVE statistics ,MANN Whitney U Test ,CHI-squared test ,CANCER patients ,KAPLAN-Meier estimator ,LOG-rank test ,NASOPHARYNX cancer ,COMPARATIVE studies ,DATA analysis software ,CONFIDENCE intervals ,COMORBIDITY ,PROPORTIONAL hazards models ,OLD age - Abstract
Background Few studies have assessed the comprehensive associations among comorbid diseases in elderly patients with nasopharyngeal carcinoma (NPC). This study sought to identify potential comorbidity patterns and explore the relationship of comorbidity patterns with the mortality risk in elderly patients with NPC. Methods A total of 452 elderly patients with NPC were enrolled in the study. The network analysis and latent class analysis were applied to mine comorbidity patterns. Propensity score matching was used for adjusting confounders. A restricted cubic spline model was used to analyze the nonlinear association between age and the risk of all-cause mortality. Results We identified 2 comorbidity patterns, metabolic disease-related comorbidity (MDRC) and organ disease-related comorbidity (ODRC) in elderly patients with NPC. Patients in MDRC showed a significantly higher risk of all-cause mortality (71.41% vs 87.97%, HR 1.819 [95% CI, 1.106-2.994], P = .031) and locoregional relapse (68.73% vs 80.88%, HR 1.689 [95% CI, 1.055-2.704], P = .042). Moreover, in patients with MDRC pattern, we observed an intriguing inverted S-shaped relationship between age and all-cause mortality among patients aged 68 years and older. The risk of mortality up perpetually with age increasing in ODRC group, specifically within the age range of 68-77 years (HR 4.371, 1.958-9.757). Conclusion Our study shed light on the potential comorbidity patterns in elderly patients with NPC, thereby providing valuable insights into the development of comprehensive health management strategies for this specific population. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in elderly patients with stage III‐IVa nasopharyngeal carcinoma: A real‐world study based on medical comorbidities.
- Author
-
Jin, Ya‐Nan, Xiao, Zhi‐Wen, Yao, Wei, Yu, Jing, Zhang, Wang‐Jian, Marks, Tia, Zhang, Hong‐Yu, Yao, Ji‐Jin, and Xia, Liang‐Ping
- Subjects
OLDER patients ,NEOADJUVANT chemotherapy ,NASOPHARYNX cancer ,POISONS ,CHEMORADIOTHERAPY ,LEUCOPENIA ,NASOPHARYNX tumors - Abstract
Purpose: To evaluate the outcomes and toxicities of adding neoadjuvant chemotherapy (NAC) to concurrent chemoradiotherapy (CCRT) in elderly (≥65 years) patients with locoregionally advanced nasopharyngeal carcinoma (LANPC, stage III‐IVa). Methods and Materials: Using an NPC‐specific database, 245 elderly patients with stage III‐IVa NPC, receiving CCRT +/− NAC, and an Adult Co‐morbidity Evaluation 27 (ACE‐27) score <2 were included. Recursive partitioning analysis (RPA) based on TNM stage and Epstein–Barr virus (EBV) DNA were applied for risk stratification. The primary end point was disease‐free survival (DFS). Results: Two risk groups were generated by the RPA model. In the high‐risk group (EBV DNA < 4000 copy/ml with stage IVa & EBV DNA ≥4000 copy/ml with stage III‐IVa), patients treated with NAC plus CCRT achieved improved 5‐year DFS rates compared to those who received CCRT alone (56.9% vs. 29.4%; p = 0.003). But we failed to observe the survival benefit of additional NAC in the low‐risk group (EBV DNA <4000 copy/ml with stage III). The most common severe acute toxic effects were leucopenia (46.8% vs. 24.4%) and neutropenia (43.7% vs. 20.2%) in the NAC plus CCRT group versus CCRT group with statistically significant differences. Conclusions: The addition of NAC to CCRT was associated with better DFS for the high‐risk group of elderly LANPC patients with ACE‐27 score <2. However, the survival benefit of additional NAC was not observed in low‐risk patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Loco‐regional radiotherapy in de novo metastatic nasopharyngeal carcinoma with chemotherapy and immunotherapy: A real‐world retrospective study from two cancer centers.
- Author
-
Ma, Li, Lan, Fengming, Chen, Peng, Lei, Ling, Zou, Teng, Fu, Fangmeng, Wu, Runye, Jin, Jing, and Zhang, Jianghu
- Subjects
NASOPHARYNX cancer ,CANCER chemotherapy ,IMMUNOTHERAPY ,RADIOTHERAPY ,METASTASIS - Abstract
Background: Immunochemotherapy has become the first‐line treatment for initial diagnosed metastatic nasopharyngeal carcinoma (mNPC). Loco‐regional radiotherapy combined with systemic chemotherapy significantly improves the survival. However, the safety and efficacy of loco‐regional radiotherapy combined with immunochemotherapy remained unknown. Methods: Patients with de novo mNPC who received immunochemotherapy followed by loco‐regional radiotherapy were included from two cancer centers. Toxicity and treatment response were assessed using CTCAE 5.0 and RECIST 1.1, respectively. Overall survival (OS) and progression‐free survival (PFS) were analyzed using the Kaplan–Meier method. Results: From 2019 to 2021, a total of 16 patients were retrospectively analyzed. The median follow‐up was 28 months (range 14–47 months). No one died. One‐year, 2‐year, and 3‐year PFS rate was 93.8%, 58.4% and 50.1%, respectively. Radiotherapy‐related acute severe (grade 3 or higher) toxicity was dermatitis (1/16, 6.3%) and mucositis (2/16, 12.5%). Conclusions: Loco‐regional radiotherapy provided a promising efficacy with modest toxicity for patients with mNPC who received immunochemotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Roles and mechanisms of circular RNA in respiratory system cancers.
- Author
-
Nan Yang, Mengwen Jiao, Yuewen Zhang, Shaokang Mo, Ling Wang, and Jianqing Liang
- Subjects
NON-small-cell lung carcinoma ,CIRCULAR RNA ,RESPIRATORY organs ,NASOPHARYNX cancer ,SQUAMOUS cell carcinoma - Abstract
Circular RNAs (circRNAs) constitute a class of endogenous non-coding RNAs (ncRNAs) that lack a 5'-ended cap and 3'-ended poly (A) tail and form a closed ring structure with covalent bonds. Due to its special structure, circRNA is resistant to Exonuclease R (RNaseR), making its distribution in the cytoplasm quite rich. Advanced high-throughput sequencing and bioinformatics methods have revealed that circRNA is highly conserved, stable, and disease- and tissue-specific. Furthermore, increasing research has confirmed that circRNA, as a driver or suppressor, regulates cancer onset and progression by modulating a series of pathophysiological mechanisms. As a result, circRNA has emerged as a clinical biomarker and therapeutic intervention target. This article reviews the biological functions and regulatory mechanisms of circRNA in the context of respiratory cancer onset and progression. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Genetic variants of LncRNAs HOTTIP and MEG3 influence nasopharyngeal carcinoma susceptibility and clinicopathologic characteristics in the Southern Chinese population.
- Author
-
Lao, Xiaoxia, Wang, Yujie, Huang, Rongxin, He, Yanying, Lu, Huabiao, and Liang, Dan
- Subjects
- *
GENETICS of disease susceptibility , *RISK assessment , *LYMPH nodes , *RESEARCH funding , *CANCER invasiveness , *SYMPTOMS , *REVERSE transcriptase polymerase chain reaction , *GENETIC polymorphisms , *RNA , *METASTASIS , *GENE expression , *NASOPHARYNX cancer , *DISEASE susceptibility , *SEQUENCE analysis , *GENOTYPES , *ALLELES , *DISEASE risk factors - Abstract
Objective: Recent studies have indicated that HOTTIP and MEG3 are associated with the initiation and progression of various types of tumors, including nasopharyngeal carcinoma (NPC). This investigation aimed to elucidate the impact of HOTTIP and MEG3 polymorphisms on the susceptibility and clinicopathologic characteristics of NPC. Methods: This research employed next-generation sequencing and multiplex PCR to assess the polymorphisms of HOTTIP rs1859168 and MEG3 rs7158663 in 200 NPC and 200 healthy individuals respectively. HOTTIP and MEG3 expression were assessed via qRT-PCR assessment. Furthermore, the genotypes and alleles frequency of rs1859168 and rs7158663 were compared between healthy and NPC individuals to elucidate their influence on NPC susceptibility and relation with clinicopathologic characteristics. Results: In comparison with the healthy cohort, the presence of HOTTIP rs1859168 CC genotype and the C allele were markedly linked with increased NPC incidence (p < 0.05). Furthermore, the MEG3 rs7158663 AA genotype and the A allele also indicated an increased risk of NPC (p < 0.05). The subgroup analysis of age, EBV infection, gender, nationality, smoking, and drinking status revealed no marked association between rs1859168 and rs7158663 genotypes and these potential confounding factors. Moreover, it was observed that rs1859168 CC and rs7158663 AA genotypes were related to local tumor invasion and lymph node metastasis. Additionally, HOTTIP indicated a marked elevation, while MEG3 substantially reduced in NPC samples than the normal nasopharyngeal biospecimens. Patients who carried CC or CA genotypes rather than the HOTTIP rs1859168 AA genotype, had substantially higher HOTTIP levels, while patients with rs7158663 AA or GA genotypes indicated notably lower expression of MEG3 than GG genotype carriers. Conclusion: Individuals with genetic variants of HOTTIP rs1859168 and MEG3 rs7158663 might have an increased risk of NPC susceptibility and related clinicopathologic characteristics, potentially by affecting the expression of HOTTIP and MEG3. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Detection of cytotoxic effects of carboplatin in human nasopharyngeal carcinoma epithelioid cell line CNE-1 by Raman spectroscopy combined with multivariate statistical analysis.
- Author
-
Chen, Weiwei, Weng, Shenghe, Zhong, Weixiong, Huang, Hao, Liang, JianXi, Yang, Jian, Du, Shiyuan, Wei, Guoqiang, Hong, Quanxing, and Yu, Yun
- Subjects
- *
NASOPHARYNX cancer , *FISHER discriminant analysis , *CELL lines , *CARBOPLATIN , *RAMAN spectroscopy , *PRINCIPAL components analysis , *MULTIVARIATE analysis , *PROGRESSION-free survival - Abstract
AbstractRaman spectroscopy combined with multivariate analysis was used to examine the molecular mechanism of carboplatin toxicity in human nasopharyngeal carcinoma epithelioid cell line CNE-1. Multivariate analysis was performed through principal component analysis combined with linear discriminant analysis, through which a diagnostic algorithm that could discriminate between the control and treatment groups was generated. Compared with the control group (0 μmol/L, 0 hour), the 2 protein Raman peaks (1002 cm−1 and 1659 cm−1) and the 2 deoxyribonucleic acid Raman peaks (1303 cm−1 and 1338 cm−1) in the treatment group decreased with increasing carboplatin concentrations as well as with increasing treatment durations. Using principal component analysis combined with linear discriminant analysis, the discrimination accuracy, sensitivity, and specificity between the control group and the cell groups treated at 12 and 16 μmol/L carboplatin for 24 hours were all 100%, suggesting that 16 μmol/L is suitable as the therapeutic dosing. Using the same method, the discrimination accuracy, sensitivity, and specificity between the control group and the cell groups that were treated with 12 μmol/L carboplatin for 24 and 36 hours were all 100%, indicating that 24 hours could be suitable treatment duration. These results suggest that Raman spectroscopy combined with multivariate statistical analysis could be a useful tool for assessing carboplatin-induced cytotoxicity in human nasopharyngeal carcinoma cells. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Analysis of the clinical efficacy and safety of anti‐PD‐1 immune checkpoint inhibitors in locally advanced nasopharyngeal cancer.
- Author
-
Shi, Shuling, Li, Bingyan, Zhou, Pengcheng, Chen, Linhui, Li, Huizhen, Wang, Yingyi, Deng, Xiaoyu, Dang, Qianqian, Wu, Jingjing, Zha, Boya, Li, Peihong, Zheng, Yingjuan, and Yang, Daoke
- Subjects
- *
IMMUNE checkpoint inhibitors , *NASOPHARYNX cancer , *IMMUNOTHERAPY , *CONTROL groups , *CHEMORADIOTHERAPY - Abstract
Objective: To analyze the efficacy and adverse effects of anti‐PD‐1 immune checkpoint inhibitors aimed at nasopharyngeal carcinoma (NPC). Methods: During the first stage of the study, using 40 patients with stage III/IVa NPC treated with anti‐PD‐1 immune checkpoint inhibitors in combination with chemoradiotherapy as a first‐line treatment (observation group) and 70 patients with NPC treated with chemoradiotherapy alone (control group). In the second stage of the study, 88 patients with NPC treated with immune checkpoint inhibitors were grouped according to the number of lines of immunotherapy, the number of times, and the types of application. Results: Observation of the short‐term effects in the first stage indicated that the objective response rate (ORR) of the observation group and the control group against primary foci of NPC was 75.0% versus 40.0%; the mortality rate of the observation group was much lower than that of the control group. The overall first‐line treatment evaluation of the observation vs. control groups were as follows: ORR (67.5% vs. 38.6%); median PFS (17.52 vs. 17.21 months); and median OS (18.68 vs. 18.14 months), respectively (p < 0.05). The second stage of the study had an ORR of 53.4%, and the efficacy of immunotherapy was related to staging, timing, and frequency. Conclusion: Anti‐PD‐1 immune checkpoint inhibitors combined with chemoradiotherapy as the first‐line treatment for nasopharyngeal carcinoma may improve patient outcomes significantly. Timing, frequency, and the type of immunotherapy exerted an effect on the efficacy of immunotherapy. Adverse effects that occurred during treatment were tolerable and controllable. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Effect of Online Clinic on Follow-Up Compliance and Survival Outcomes in Nasopharyngeal Carcinoma: Real-World Cohort Study from Endemic Area.
- Author
-
Chen, Siqi, Feng, Chenyang, Sun, Peng, Zhang, Jingrong, and Liang, Hu
- Subjects
PATIENT compliance ,RESEARCH funding ,LOGISTIC regression analysis ,DESCRIPTIVE statistics ,CHI-squared test ,MANN Whitney U Test ,MULTIVARIATE analysis ,TELEMEDICINE ,LONGITUDINAL method ,KAPLAN-Meier estimator ,LOG-rank test ,ODDS ratio ,STATISTICS ,NASOPHARYNX cancer ,SURVIVAL analysis (Biometry) ,DATA analysis software ,CONFIDENCE intervals ,PROGRESSION-free survival ,PATIENT aftercare ,PROPORTIONAL hazards models - Abstract
Nasopharyngeal carcinoma (NPC) requires regular follow-up to detect recurrence as early as possible. However, many patients are unable to regularly follow up due to the inconvenience of the conventional approach. Therefore, this study was designed to investigate the impact of the online clinic on follow-up compliance and prognosis in NPC patients. Patients who were first diagnosed with NPC between April 2019 and November 2019 were enrolled. Good follow-up compliance was defined as having at least one follow-up visit every 6 months within 2 years after treatment completion. Sensitivity analyses were performed using a propensity score matching model. A total of 539 (42%) patients used online follow-up while 731 (58%) used traditional follow-up. The median age of patients in the online cohort was lower than that in the traditional cohort (44 vs. 47, p < 0.001). Compared with the traditional cohort, the online cohort had significantly better follow-up compliance (57.3% vs. 17.1%, p < 0.001) and a higher 2-year PFS rate (98.1% vs. 94.4%, p = 0.003). Survival analysis showed that online follow-up was an independent factor for better survival prognosis (HR 0.39, 95%CI 0.20–0.74, p = 0.004). Sensitivity analysis further confirmed these results. Our study found that the online clinic increased follow-up compliance and improved prognosis in NPC patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Global trends in research of nasopharyngeal carcinoma: a bibliometric and visualization analysis.
- Author
-
Guilin An, Jie Liu, Ting Lin, Lan He, and Yingchun He
- Subjects
BIBLIOMETRICS ,NASOPHARYNX cancer ,CANCER stem cells ,RADIOBIOLOGY ,EPITHELIAL-mesenchymal transition - Abstract
Objective: This study aims to assess the current research status, focus areas, and developmental trends in nasopharyngeal carcinoma (NPC) through a bibliometric analysis. Methods: Articles focusing on NPC published from 2000 to 2023 were retrieved from the Web of Science database. VOSviewer and CiteSpace were used for bibliometric and visual analysis. Results: A total of 14516 related publications were retrieved. There has been a steady increase in the number of NPC-related publications from 2000 to 2023. China was the dominant country in this field with 8948 papers (61.64%), followed by the USA (2234, 15.39%). Sun Yat-sen University was the most influential institution, while Ma J was the most prolific author. Furthermore, Head And Neck-journal For The Sciences And Specialties Of The Head And Neck was the most prolific journal. International Journal of Radiation Oncology Biology Physics had the highest total citation counts. "Introduction chemotherapy", "Concurrent chemotherapy", "Epithelial-mesenchymal transition", "Cancer stem cells", "MicroRNAs", "LncRNA", "Exosomes", and "Biomarker" were the most common keywords. The reference "Chen YP, 2019, Lancet" had the highest citations and strong outbreak value. Conclusion: The past two decades have witnessed a significant increase in research on NPC. The optimization of treatment mode is the most widely studied aspect at present. The mechanism of occurrence and development and the most favorable diagnostic and therapeutic targets are the research hotspots in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. IgG4-related disease with nasopharyngeal malignancy-like manifestations.
- Author
-
Xijun Lin, Peiliang Lin, Jianming Fan, Biying Zhang, Faya Liang, Ping Han, Xiang Liu, and Xiaoming Huang
- Subjects
NASOPHARYNX cancer ,SYMPTOMS ,PLASMA cells ,DISEASE duration ,RHINORRHEA ,NASOPHARYNX tumors ,NASOPHARYNX diseases - Abstract
Background: IgG4-related disease (IgG4-RD) was characterized by single or multiple masses in organs, which may mimic various inflammatory and malignant diseases. Here, we summarize 4 patients with aggressive manifestations of IgG4-RD that mimic nasopharynx cancer to provide some new sights for the diagnosis of IgG4-RD. Case summary: Four patients were included in our series. The age ranged from 53 to 64 years old, and the duration of the disease ranged from 4 to 6 months. The chief complaints included headache, rhinorrhea, or diplopia. All patients had more than 10 IgG4+ plasma cells/HPF in immunohistochemistry with plasma lgG4 levels ranging from 218 mg/dL to 765 mg/dL. All of them met the diagnostic criteria of lgG4-RD. Conclusion: The described case is highly similar to the clinical manifestations of nasopharyngeal carcinoma. Although pathology is the gold standard, there are still limitations. Serological IgG4 can help confirm the diagnosis. Timely diagnosis of IgG4-RD is of great significance in preventing secondary organ damage in patients with active diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. METTL14 contributes to the progression of nasopharyngeal carcinoma through regulating the stability of AOC1 mRNA.
- Author
-
Hu, Changan, Song, Shengguan, Zhao, Shanglong, Xue, Zhen, and Zhu, Xiwen
- Subjects
- *
NASOPHARYNX cancer , *MESSENGER RNA , *AMINE oxidase , *POLYMERASE chain reaction , *TUMOR growth , *FORMYLATION - Abstract
Background: Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor of the nasopharyngeal mucosa with a high incidence rate all over the world. Methyltransferase-like 14 (METTL14) is a major RNA N6-adenosine methyltransferase implicated in tumor progression by regulating RNA function. This study is designed to explore the biological function and mechanism of METTL14 in NPC. Methods: METTL14 and Amine oxidase copper containing 1 (AOC1) expression were detected by real-time quantitative polymerase chain reaction (RT-qPCR). The protein levels of METTL14, AOC1, Cyclin D1, B-cell lymphoma-2 (Bcl-2), and N-cadherin were measured using western blot. Cell proliferation, cycle progression, apoptosis, migration, and invasion were assessed using 5-ethynyl-2'-deoxyuridine (EdU), Colony formation, flow cytometry, wound scratch, and transwell assays. The interaction between METTL14 and AOC1 was verified using RNA immunoprecipitation (RIP), methylated RNA immunoprecipitation (MeRIP), and dual-luciferase reporter assays. The biological role of METTL14 on NPC tumor growth was examined by the xenograft tumor model in vivo. Results: METTL14 and AOC1 were highly expressed in NPC tissues and cells. Moreover, METTL14 knockdown might block NPC cell proliferation, migration, invasion, and induce cell apoptosis in vitro. In mechanism, METTL14 might enhance the stability of AOC1 mRNA via m6A methylation. METTL14 silencing might repress NPC tumor growth in vivo. Conclusion: METTL14 might boosted the development of NPC cells partly by regulating the stability of AOC1 mRNA, which provided a promising therapeutic target for NPC treatment. Highlights: 1. METTL14 expression was upregulated in NPC tissues and cell lines. 2. METTL14 knockdown suppressed NPC cell growth and metastasis. 3. METTL14 improved the stability of AOC1 mRNA AOC1 via m6A methylation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Research progress on anti-cancer mechanism of salidroside regulating miRNA-mRNA signaling axis.
- Author
-
Wu, Xiaoxiong, Zhang, Zhendong, and Wang, Xiaoping
- Subjects
- *
CANCER cell proliferation , *TIBETAN medicine , *CELL cycle , *NASOPHARYNX cancer , *TUMOR microenvironment , *BLADDER cancer ,NASOPHARYNX tumors - Abstract
MiRNA (MicroRNA) can target and regulate mRNA, thereby influencing the biological processes of tumors. The extract of Tibetan medicine Rhodiola demonstrates anti-tumor effects by targeting and regulating cancer-related signaling molecules and pathways. This review aims to pave the way for integrating salidroside into clinical practice, fully leverage its multi-effective and multi-targeted biological effects, and innovate approaches to tumor prevention and management, thus enhancing cancer prognosis. We initially delve into the occurrence and mechanism of action of miRNA, as well as the anti-tumor mechanism of the miRNA-mRNA signaling axis. Additionally, it was described that salidroside can hinder cancer cell proliferation by inducing autophagy and apoptosis, inhibiting cell metastasis and invasion, and modulating the tumor microenvironment and cell cycle. Moreover, examples from lung cancer, gastric cancer, and nasopharyngeal carcinoma confirm that salidroside regulates the onset and progression of tumors through the miRNA-mRNA signaling axis. This groundbreaking discovery carries significant implications for cancer diagnosis and treatment, offering a novel pathway for therapeutic intervention. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience.
- Author
-
Majidova, Nargiz, Sarı, Murat, Kahvecioglu, Fatma Akdag, Ozcan, Erkan, Akdag, Mutıianur Ozkorkmaz, Dogan, Akif, Yıldırım, Sedat, Sonusen, Sermin Dinc, Yunusov, Emil, Yasar, Alper, Celebi, Abdussamet, Sever, Nadiye, Kocaaslan, Erkam, Erel, Pınar, Agyol, Yesım, Guren, Alı Kaan, Arıkan, Rukıye, Isık, Selver, Balvan, Ozlem, and Geredelı, Caglayan
- Subjects
- *
INDUCTION chemotherapy , *NASOPHARYNX cancer , *OVERALL survival , *PROGRESSION-free survival , *SURVIVAL rate - Abstract
Introduction: Nasopharyngeal carcinoma (NPC) accounts for 0.01% of all carcinomas, and 70% of patients have locally advanced disease with a poor prognosis. The mainstay therapy is chemoradiotherapy (CRT), and concurrent administration of platinum-based agents and irradiation provides high local control rates. However, induction (neoadjuvant) chemotherapy (ICT) prior to CRT is recommended for large tumors with a high tumor burden at the category 1 level. For ICT, platinum-based doublet or triplet combination regimens are recommended. Selected patients with a high tumor burden at the time of diagnosis who did not receive ICT before CRT were given adjuvant (consolidation) therapy after CRT. This multicenter study aimed to share our experience in treatment of NPC and evaluate the factors associated with survival. Methods: The study included patients diagnosed with NPC who were followed and treated between 2008 and 2022. Hundred and forty-two patients from 6 centers were evaluated. The factors associated with disease-free survival (DFS) and overall survival (OS) were evaluated. Results: The median age of our patients was 51 years (IQR: 16–81 years), and the male:female ratio was 2.5:1. A majority of patients (71%) had stage 3–4 disease. They had locally advanced disease, and 48 patients (34%) received ICT. Twenty patients (14%) received adjuvant therapy. The median follow-up was 41 months (range, 2.7–175.1 months). The median DFS in NPC was 92.6 months (range, 71.9–113.3 months), with a 40th month DFS of 70.9%. The median OS was 113 months (range, 91–135 months), with a 40th month OS of 84.7%. Median DFS was 95.3 months (range, 64.2–126.4 months) in patients who received ICT before CRT, which was longer than in the CRT-only group (p = 0.6). DFS at the 40th month was 75.1% in patients treated with ICT compared to 65.1% in the CRT-only group. Median OS was 117 months (range, 92–142 months) in patients receiving ICT, which was longer than in the CRT-only group (p = 0.4). OS at the 40th month was 86.7% in patients receiving ICT but 83.6% in the CRT-only group. Conclusions: Both the objective response rate and survival were longer in patients who radiologically responded to CRT following ICT. Nonresponse to ICT is a negative predictive indicator. The role of ICT in locally advanced NPC is increasing. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Automatic Annotation Diagnostic Framework for Nasopharyngeal Carcinoma via Pathology–Fidelity GAN and Prior-Driven Classification.
- Author
-
Zeng, Siqi, Li, Xinwei, Liu, Yiqing, Huang, Qiang, and He, Yonghong
- Subjects
- *
IMAGE recognition (Computer vision) , *ARTIFICIAL intelligence , *NASOPHARYNX cancer , *CANCER diagnosis , *DIAGNOSIS methods - Abstract
Non-keratinizing carcinoma is the most common subtype of nasopharyngeal carcinoma (NPC). Its poorly differentiated tumor cells and complex microenvironment present challenges to pathological diagnosis. AI-based pathological models have demonstrated potential in diagnosing NPC, but the reliance on costly manual annotation hinders development. To address the challenges, this paper proposes a deep learning-based framework for diagnosing NPC without manual annotation. The framework includes a novel unpaired generative network and a prior-driven image classification system. With pathology–fidelity constraints, the generative network achieves accurate digital staining from H&E to EBER images. The classification system leverages staining specificity and pathological prior knowledge to annotate training data automatically and to classify images for NPC diagnosis. This work used 232 cases for study. The experimental results show that the classification system reached a 99.59% accuracy in classifying EBER images, which closely matched the diagnostic results of pathologists. Utilizing PF-GAN as the backbone of the framework, the system attained a specificity of 0.8826 in generating EBER images, markedly outperforming that of other GANs (0.6137, 0.5815). Furthermore, the F1-Score of the framework for patch level diagnosis was 0.9143, exceeding those of fully supervised models (0.9103, 0.8777). To further validate its clinical efficacy, the framework was compared with experienced pathologists at the WSI level, showing comparable NPC diagnosis performance. This low-cost and precise diagnostic framework optimizes the early pathological diagnosis method for NPC and provides an innovative strategic direction for AI-based cancer diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Randomised controlled trial of Jiandu granule in preventing chemoradiotherapy‐induced oral mucositis.
- Author
-
Li, Huakang, Ke, Jianlong, Wang, Xiaoyan, Xu, Bo, Li, Qiang, Wu, Ziliang, Wang, Yue, and Lin, Bing
- Subjects
- *
CHINESE medicine , *STOMATITIS , *RESEARCH funding , *HERBAL medicine , *STATISTICAL sampling , *CHEMORADIOTHERAPY , *TREATMENT effectiveness , *RANDOMIZED controlled trials , *NASOPHARYNX cancer , *GASTROINTESTINAL diseases , *DISEASE complications - Abstract
Objective: This clinical trial aimed to evaluate the efficacy and safety of Jiandu granule, a Chinese herbal medicine formula, for preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy. Materials and Methods: A single‐centre, open‐label, randomised controlled trial was conducted, enrolling 138 patients with locally advanced nasopharyngeal carcinoma. Patients were randomly allocated to either the experimental group (n = 69) or the control group (n = 69). Both groups received concurrent chemoradiotherapy and standard care for oral mucositis, with the experimental group additionally receiving Jiandu granule intervention. The primary outcome was the incidence of severe oral mucositis (grade III to IV). Results: In the full‐analysis set, severe oral mucositis occurred in 14 of 69 (20.3%) patients in the experimental group and 31 of 69 (44.9%) patients in the control group (absolute risk reduction: 24.6%; relative risk reduction: 54.8%; p = 0.002; number needed to treat: 4). Jiandu granule was associated with mild/moderate gastrointestinal reactions, with an overall incidence of 5.9%. Conclusion: Jiandu granule reduced the incidence of severe oral mucositis in nasopharyngeal carcinoma patients during concurrent chemoradiotherapy and had an acceptable safety profile. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Post‐radiation middle ear effusion in NPC patients: Analysis of patient, tumour, and radiation factors.
- Author
-
Vainer, Igor, Tzelnick, Sharon, Kurman, Noga, Popovtzer, Aron, and Soudry, Ethan
- Subjects
- *
OTITIS media with effusion , *EUSTACHIAN tube , *MIDDLE ear , *NASOPHARYNX cancer , *RADIATION doses , *RADIATION injuries , *OTITIS media - Abstract
Objective: The purpose of this study was to investigate whether patient, tumour and radiation therapy factors are associated with development of middle ear effusion (MEE) in nasopharyngeal carcinoma (NPC) patients. Deign, Settings, and Participants: A retrospective review of NPC patients treated between January 2000 and June 2018 at Rabin Medical Center. Patient factors, tumour factors, radiation doses, and radiation fields were collected and outlined if needed (middle ear, eustachian tube [ET], tensor veli palatini [TVP], and levator palatini [LVP] muscles), then analysed and compared between patients with MEE and those without and between sides in patients with unilateral MEE. Main Outcome Measures and Results: Seventy‐three patients were enrolled. Most were males (71.2%) with advanced‐stage diseases (78%). At the time of diagnosis 14 patients (19.2%) presented with MEE. Following radiation, 18 patients, with no evidence of MEE at presentation, developed MEE. Tumour stage, histology, and laterality were not associated with development of MEE. Comparison of mean radiation field dosages including—gross target volume, clinical target volume, and patient target volume showed no association with post‐radiation MEE. In addition, no difference was found in the radiation doses to the middle ear, ET or the LVP nor the TVP between ears with and without MEE. Conclusions: Post‐irradiation MEE remains a common adverse effect in NPC patients. Surprisingly, tumour stage, tumour laterality, and histology were not associated with MEE. Similar findings were observed for total radiation doses and specific doses to the middle ear, ET, and ET muscles. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Patterns of failure in patients with nasopharyngeal cancer of Northeastern region of India: a retrospective observational study.
- Author
-
Bhattacharyya, Mouchumee, Medhi, Partha Pratim, Sharma, Prashasti, Nath, Jyotiman, Kalita, Apurba Kumar, Roy, Partha Sarathi, Rahman, Tashnin, and Yanthan, Yanpothung
- Subjects
- *
NASOPHARYNX cancer , *PROGRESSION-free survival , *CANCER patients , *NASOPHARYNX diseases , *PROPORTIONAL hazards models , *OVERALL survival - Abstract
Purpose: We aimed to analyze patterns of failure and disease volume-treatment outcomes in patients with Nasopharyngeal carcinoma (NPC) treated with definitive radiation with or without concurrent chemotherapy at a tertiary cancer centre in northeast India. Methods: From February 2018 to February 2022, 99 histopathologically proved non-metastatic NPC patients treated with curative-intent RT with or without chemotherapy were retrospectively analyzed. Locally advanced patients received neoadjuvant or adjuvant chemotherapy. The Cox proportional hazards model was used to investigate the impact of various prognostic factors on locoregional free survival (LRFS), distant metastasis free survival (DMFS), progression free survival (PFS) and overall survival (OS). The log-rank test and Kaplan–Meir curves compared outcome variables based on ROC analysis-classified tumor volume. Results: During a median follow up of 25.4 months (17.3–39.2), 35(35.4%) patients developed recurrence. Twenty-three patients developed locoregional failures, of which 11 were in-field; 12 patient showed an out-field failure. The 3-year LRFS, DMFS, PFS and OS was 71.10%, 70.90%, 64.10% and 74.10% respectively. There was statistically significant difference in LRFS according to T staging (p < 0.0001). Gross tumor volume (GTVp) and gross nodal volume (GTVn) were an independent prognostic factor for OS, PFS, LRFS and DMFS. The cut-off volumes for GTVp and GTVn for distant metastases and locoregional failure, respectively, were found to be 13 and 22.7 mL and 3.7 and 39.2 mL, respectively, by ROC curve analysis. Based on this, 99 patients were divided into three subgroups. OS demonstrated significant differences among patients in different volume subgroups for GTVp (p = 0.03) and GTVn (p = 0.00024). Conclusions: For NPC patients who undergo curative IMRT, primary tumour and nodal volumes are independent prognostic indicators. GTVp and GTVn are highly predictive of local control, distant metastases, disease-free survival, and overall survival. This justifies their use as quantitative prognostic indicator for NPC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Impact of magnetic resonance imaging-derived skeletal muscle index in locoregionally advanced nasopharyngeal carcinoma.
- Author
-
Jiang, Jiali, Cai, Zhuochen, Zheng, Ronghui, Yuan, Yawei, Lv, Xing, and Qiu, Wenze
- Subjects
- *
NASOPHARYNX cancer , *MAGNETIC resonance imaging , *SKELETAL muscle , *MAGNETIC resonance , *INDUCTION chemotherapy ,NASOPHARYNX tumors - Abstract
Purpose: To evaluate the clinical implication of magnetic resonance imaging (MRI)-derived skeletal muscle index (SMI) in locoregionally advanced nasopharyngeal carcinoma (LANPC) patients undergoing induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CCRT) and further to develop a nomogram for predicting survival prognosis. Methods: SMI was determined through baseline MRI at the third cervical level. The nomogram was based on a training cohort involving 409 LANPC patients. We validated the prognostic accuracy of this prognostic model in an internal validation cohort (n = 204) and an external independent cohort (n = 272). Results: SMI was an independent risk factor for OS. A prognostic model comprising age, TNM stage and SMI for individual survival prediction was developed and graphically represented as a nomogram. The model showed favorable discrimination (C-index: 0.686), predictive accuracy [time dependent area under the curve (tAUC) at 5 years: 0.70], and calibration, and was further validated in the internal and external validation datasets. A risk stratification derived from the model stratified these patients into three prognostic subgroups with significantly different survival. Conclusions: Low SMI accessed by MRI was significantly associated with poor overall survival in LANPC patients undergoing IC + CCRT. Moreover, we established and validated a novel nomogram involving age, TNM stage and SMI that could provide accurate prognostic stratification among this population. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma in a non-endemic area.
- Author
-
Valentini, Marco, Lambertoni, Alessia, Sileo, Giorgio, Arosio, Alberto Daniele, Dalfino, Gianluca, Pedretti, Fabio, Karligkiotis, Apostolos, Bignami, Maurizio, Battaglia, Paolo, Castelnuovo, Paolo, and Turri-Zanoni, Mario
- Subjects
- *
NASOPHARYNX cancer , *PATIENT selection , *SKULL base , *PROGRESSION-free survival , *PROGNOSIS ,NASOPHARYNX tumors - Abstract
Purpose: To analyze oncological outcomes of endoscopic surgical treatment of locally recurrent EBV-related undifferentiated non-keratinizing nasopharyngeal carcinoma (uNK-NPC) in a non-endemic area. Methods: Retrospective review of patients affected by recurrent uNK-NPC treated with nasopharyngeal endoscopic resection (NER) in a tertiary-care referral center from 2003 to 2022, by evaluating survival rates, prognostic factors, and follow-up strategies. Results: The oncological outcomes of 41 patients were analyzed, over a mean follow-up period of 57 months. The 5-year overall, disease-specific, and disease-free survival of the cohort were 60.7% ± 8.9%, 69% ± 9%, and 39.7% ± 9.2%, respectively. The local (rT) and regional (rN) extension of recurrent disease, stage of disease, and status of resection margins appeared to significantly influence survivals. After a mean follow-up period of 21 months, a further recurrence after NER was observed in 36.6% of cases. Skull base osteonecrosis induced by previous irradiation and post-surgical bone remodeling represent the major challenges for early detection of further local relapses during postoperative follow-up. Conclusion: NER appeared as a safe and effective treatment for recurrent uNK-NPC. The adequate selection of patients eligible for NER is essential, to maximize the chances to cure and minimize the risk of local complications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. RETRACTION: CircRNA EPHB4 modulates stem properties and proliferation of gliomas via sponging miR‐637 and up‐regulating SOX10.
- Subjects
- *
CELL proliferation , *SOX transcription factors , *GLIOMAS , *MOLECULAR oncology , *CIRCULAR RNA , *NASOPHARYNX cancer - Abstract
Retraction: C. Jin, J. Zhao, Z‐P. Zhang, M. Wu, J. Li, B. Liu, X‐B. Liao, Y‐X. Liao, and J‐P. Liu, “CircRNA EPHB4 modulates stem properties and proliferation of gliomas via sponging miR‐637 and up‐regulating SOX10,” Molecular Oncology 15, no. 2 (2020): 596‐622, https://doi.org/10.1002/1878-0261.12830.The above article, version of record published online on 16 December 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor‐in‐Chief, Kevin Ryan; FEBS Press; and John Wiley & Sons Ltd. The journal began an investigation following a report from a third party regarding image duplication in Figure 14H between this article and the following articles: Gong et al. [1] and Zhao, et al. [2]. The authors did not respond to requests by the journal and the publisher for original data and an explanation. The retraction has been agreed because the evidence of image duplication across other articles substantially compromises the conclusions of the article. The authors did not respond to our notice of retraction.References[1] H. Gong , Y. Tao , S. Xiao , X. Li , K. Fang , J. Wen , P. He , and Ming, Z. “LncRNA KIAA0087 suppresses the progression of osteosarcoma by mediating the SOCS1/JAK2/STAT3 signaling pathway,” Experimental & Molecular Medicine 55 (2023): 831‐843, https://doi.org/10.1038/s12276-023-00972-8.[2] Y. Zhao , C. Li , Y. Zhang , and Z. Li . “CircTMTC1 contributes to nasopharyngeal carcinoma progression through targeting miR‐495‐MET‐eIF4G1 translational regulation axis,” Cell Death & Disease 13, no. 250 (2022), https://doi.org/10.1038/s41419-022-04686-z. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
43. Prognostic modeling for nasopharyngeal carcinoma (NC) undergoing concurrent chemoradiotherapy using clinical and enhanced MRI-Delta radiomics data: A preliminary study.
- Author
-
Wang, Qiuyang, An, Peng, Song, Lina, Liu, Junjie, and Liu, Jisheng
- Subjects
- *
NEUTROPHIL lymphocyte ratio , *MAGNETIC resonance imaging , *PROGNOSTIC models , *RADIOMICS , *NASOPHARYNX cancer - Abstract
BACKGROUND: Nasopharyngeal carcinoma (NC) is one of the prevalent malignancies of the head and neck region with poor prognosis. OBJECTIVE: The aim of this study is to establish a predictive model for assessing NC prognosis based on clinical and MR radiomics data, subsequently to develop a nomogram for practical application. METHODS: Retrospective analysis was conducted on clinical and imaging data collected between May 2010 and August 2018, involving 211 patients diagnosed with histologically confirmed NC who received concurrent chemoradiotherapy or radical surgery in Xiangyang No. 1 People's Hospital. According to 5–10 years of follow-up results, the patients were divided into two groups: the study group (n = 76), which experienced recurrence, metastasis, or death, and the control group (n = 135), characterized by normal survival. Training and testing subsets were established at a 7:3 ratio, with a predefined time cutoff. In the training set, three prediction models were established: a clinical data model, an imaging model, and a combined model using the integrated variation in clinical characteristics along with MR radiomics parameters (Delta-Radscore) observed before and after concurrent chemoradiotherapy. Model performance was compared using Delong's test, and net clinical benefit was assessed via decision curve analysis (DCA). Then, external validation was conducted on the test set, and finally a nomogram predicting NC prognosis was created. RESULTS: Univariate analysis identified that the risk factors impacting the prognosis of NC included gender, pathological type, neutrophil to lymphocyte ratio (NLR), degree of tumor differentiation, MR enhancement pattern, and Delta-Radscore (P < 0.05). The combined model established based on the abovementioned factors exhibited significantly higher predictive performance [AUC: 0.874, 95% CI (0.810–0.923)] than that of the clinical data model [AUC: 0.650, 95% CI (0.568–0.727)] and imaging model [AUC: 0.824, 95% CI (0.753–0.882)]. DCA also demonstrated superior clinical net benefit in the combined model, a finding further verified by results from the test set. The developed nomogram, based on the combined model, exhibited promising performance in clinical applications. CONCLUSION: The Delta-Radscore derived from MR radiomics data before and after concurrent chemoradiotherapy helps enhance the performance of the NC prognostic model. The combined model and resultant nomogram provide valuable support for clinical decision-making in NC treatment, ultimately contributing to an improved survival rate. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Sevoflurane inhibits the malignant behavior of nasopharyngeal carcinoma cells by regulating mitochondrial membrane potential.
- Author
-
Xuan Peng and YuLin Zhou
- Subjects
MEMBRANE potential ,MITOCHONDRIAL membranes ,NASOPHARYNX cancer ,CYTOCHROME c ,ADENOSINE triphosphate ,GLUTATHIONE peroxidase ,PYRUVATE kinase - Abstract
This study aims to determine the effect of sevoflurane (Sev) on nasopharyngeal carcinoma (NPC) in malignant behavior and mitochondrial membrane potential (MMP). NPC cells (5-8F and CNE2) were exposed to Sev at different concentrations and then tested for proliferation by CCK-8 and colony formation assays, apoptosis by flow cytometry, and invasion and migration by Transwell assays. In addition, the Warburg effect was examined by measurements of glucose consumption, lactic acid production, and adenosine triphosphate (ATP). Mitochondrial function was evaluated by reactive oxygen species (ROS) production, oxidative stress-related indexes, and mitochondrial membrane potential. Sev suppressed 5-8F and CNE2 cell proliferation, invasion, and migration, and enhanced apoptosis. Moreover, Sev dampened the Warburg effect by reducing glucose consumption, lactic acid production, and ATP, as well as decreasing hexokinase 2 and pyruvate kinases type M2 protein expressions. Also, Sev induced ROS production and malondialdehyde content and reduced superoxide and glutathione peroxidase levels. Finally, Sev caused damage to mitochondrial homeostasis through induction of cleaved caspase-3, cleaved caspase-9, and cytochrome c protein expression and reduction of MMP. Sev inhibits the malignant behavior of NPC cells by regulating MMP. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. A Nomogram Based on Platelet Distribution Width-to-Lymphocyte Ratio to Predict Overall Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.
- Author
-
Wang, Runzhi, Zhao, Rong, Liang, Zhongguo, Chen, Kaihua, and Zhu, Xiaodong
- Subjects
DISEASE risk factors ,NASOPHARYNX cancer ,OVERALL survival ,REGRESSION analysis ,CANCER hospitals - Abstract
Purpose: To evaluate the prognostic significance of platelet distribution width-to-lymphocyte ratio (PDWLR) in patients with locoregionally advanced nasopharyngeal carcinoma (LA-NPC). Moreover, a nomogram based on PDWLR was built and validated to predict the overall survival (OS) of this population. Patients and Methods: All LA-NPC patients who were diagnosed and treated between January 2015 and December 2017 at Guangxi Medical University Cancer Hospital were included. Cox regression analyses were performed to assess PDWLR and clinical features that might affect OS to screen for independent predictors. The independent predictors and important clinical variables were used to build and validate a nomogram for predicting OS. Then, the capability of the model was estimated by discrimination, calibration and clinical usefulness. Risk stratification was conducted using the nomogram-calculated risk score, and the comparison of survival in the high-risk group and the low-risk group was through Kaplan–Meier method. Results: This study included 746 LA-NPC patients. Multivariate Cox analysis suggested that age (hazard ratio [HR]: 1.81, 95% confidence interval [CI]: 1.18– 2.78, P = 0.007), gender (HR: 2.03, 95% CI: 1.12– 3.68, P = 0.019), pre-treatment plasma Epstein–Barr virus (EBV) DNA (HR: 1.55, 95% CI: 1.01– 2.39, P = 0.047), PDWLR (HR: 2.61, 95% CI: 1.67– 4.09, P < 0.001) were independent predictors of OS. Compared to the 8th edition TNM staging system, the nomogram based on the above four factors and important clinical variables (T stage and N stage) demonstrated better predictive performance. Moreover, the model had the ability to identify individuals at high risk. Conclusion: PDWLR was a promising negative predictor for patients with LA-NPC. The nomogram based on PDWLR demonstrated better predictive performance than the current staging system. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Nasopharyngeal cancer: A five-year retrospective analysis of clinical and epidemiological characteristics with survival insights.
- Author
-
Mahajan, Divya, Pandey, Awadesh Kumar, Firdous, Bushra, Mehmi, Prachi, Kaur, Navjot, and Taneja, Rishab
- Subjects
NASOPHARYNX cancer ,EPIDEMIOLOGY ,SYMPTOMS ,EPIDEMIOLOGY of cancer ,OVERALL survival ,HEAD & neck cancer - Abstract
Background: Nasopharyngeal cancer is a rare tumor with significant diversity. Head and neck cancer are common in male whereas nasopharyngeal cancer still is uncommon. There is very less data available on survival and characteristics of nasopharyngeal cancer in North India. Study design: Retrospective study. Materials and methods: The HBCR data on all nasopharyngeal cancer patients who were treated were retrieved for a period of 5 years from 2017 to 2022. Statistical analysis used: SPSS software version 20. Results: A total of 29 patients were analysed. Total male to female ratio is 1.4:1 i.e. 58.4% male and 41.4% are female. Most common age group affected is between 40 years to 60 years. Most common symptom was nasal blockade followed by neck swelling. Patient common stage of disease presentation was stage IV i.e. 45%, stage III was 34.4% and stage II was 21%. Metastasis was common in bone followed by lung and liver. In our study 59% of the patients were treated with radiation and concomitant chemotherapy. The overall survival by Kaplan meire curve at 2 years in our study population was 64.3% and 5 years survival analysis was 46.93%. Conclusion: Nasopharyngeal Carcinoma (NPC) is an infrequent head and neck malignancy in Northern India, often diagnosed at an advanced stage with a higher likelihood of distant metastasis. Concurrent chemo-radiation therapy, particularly utilizing a weekly cisplatin regimen, has demonstrated favorable outcomes and tolerability. There is a pressing need for additional prospective research to evaluate this treatment schedule further and explore the potential benefits of novel agents in managing this potentially curable malignancy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
47. Comparative evaluation of coplanar and non-coplanar vmat for nasopharynx cancer radiotherapy: Dosimetric and clinical implications.
- Author
-
El Ouardy, K., Zerfaoui, M., Rrhioua, A., Oulhouq, Y., Bakari, D., and El Hamidi, Lakbir
- Subjects
VOLUMETRIC-modulated arc therapy ,INTENSITY modulated radiotherapy ,NASOPHARYNX cancer ,MEDICAL dosimetry ,INNER ear - Abstract
This task presents a comprehensive comparative analysis of two advanced radiotherapy techniques, coplanar Volumetric Modulated Arc Therapy (cVMAT) and non-coplanar Volumetric Modulated Arc Therapy (ncVMAT), for the treatment of nasopharynx cancer. A retrospective analysis was conducted on treatment plans for ten nasopharyngeal cancer patients who underwent radiotherapy using these techniques. The present study focused on dosimetric parameters, including dose distribution to target volumes and critical organs, and clinical implications of these techniques. The results revealed that, while both cVMAT and ncVMAT showed similar performance in terms of treatment plan quality and overall dose conformity, notable differences were observed in mean doses delivered to specific organs. The brainstem, inner ears, left eye, right parotid gland, and left humeral head exhibited significant variations in mean doses between the two techniques. These findings highlight the importance of patient-specific considerations when selecting the optimal radiotherapy approach for nasopharynx cancer patients. Clinicians should carefully assess individual patient characteristics and clinical priorities to make informed treatment decisions. This work proposes practical solutions and contributes to the ongoing discussions on the choice of VMAT techniques in radiotherapy for nasopharynx cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
48. Efficacy and Safety of Re-Challenging PD-1 Inhibitors in Second-Line Treatment in Metastatic Nasopharyngeal Carcinoma Previously Treated with Chemotherapy and PD-1 Inhibitors.
- Author
-
Bei, Weixin, Dong, Shuhui, Liu, Guoying, Lin, Lanfeng, Jiang, Yaofei, Lu, Nian, Li, Wangzhong, Liang, Hu, Xiang, Yanqun, and Xia, Weixiong
- Subjects
IMMUNE checkpoint inhibitors ,COMBINATION drug therapy ,NASOPHARYNX cancer ,PROGRAMMED cell death 1 receptors ,THROMBOCYTOPENIA - Abstract
Objective response rate (ORR). Results: A total of 96 patients were eligible between January 2015 and December 2020. Thirty-seven (38.5%) were in the PD-1 ICIs re-challenge group, while the remaining 59 patients (61.5%) were in the chemotherapy group. The ORR and DCR of PD-1 ICIs group and chemotherapy group were 37.8% vs 23.7% and 86.5% vs.74.5%, respectively. After a median follow-up period of 21.1 months (IQR 16.1– 28.7), the log-rank analysis demonstrated a significantly improved PFS in the PD-1 ICIs re-challenge group compared to the chemotherapy group (8.4 months [95% CI 4.3– 14.0] vs 5.0 months [95% CI 2.8– 7.2], P = 0.03). However, no significant difference in OS was observed between the two groups (28.3 vs 24.1 months, P = 0.09). The two groups had similar adverse reactions, but the incidence of grade 3 or 4 thrombocytopenia was significantly higher in the PD-1 ICIs re-challenge group (18.9% vs 3.4%, P = 0.025). Conclusion: mNPC patients who progressed from prior anti-PD1 therapy could benefit from the anti-PD1 rechallenge in combination with chemotherapy. However, further validation is needed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Association of Matrix Metalloproteinase-9 Genotypes With Nasopharyngeal Carcinoma Risk.
- Author
-
CHAO-HSUAN CHEN, LIANG-CHUN SHIH, SHIH-WEI HSU, HUI-CHI TIEN, YEN-FANG LIU, YUN-CHI WANG, CHIA-WEN TSAI, DA-TIAN BAU, and WEN-SHIN CHANG
- Subjects
MATRIX metalloproteinases ,NASOPHARYNX cancer ,CANCER risk factors ,GENOTYPES ,CANCER genetics ,POLYMERASE chain reaction - Abstract
Background/Aim: The up-regulation of matrix metalloproteinase-9 (MMP-9) expression is a characteristic feature observed across various malignancies, including nasopharyngeal carcinoma (NPC). Nevertheless, the influence of MMP-9 genotype in the context of NPC remains underexplored. This study examined the implications of MMP-9 promoter rs3918242 genotypes on the susceptibility to NPC in Taiwan. Materials and Methods: In a cohort comprising 208 NPC cases and 416 healthy controls, genotyping of MMP-9 rs3918242 was conducted utilizing polymerase chain reaction-restriction fragment length polymorphism methodology. Results: Individuals harbouring the variant CT or TT genotype of MMP-9 rs3918242 did not demonstrate a discernible alteration in NPC risk when compared to wild-type CC carriers [odds ratio (OR)=0.83 and 0.79, with 95% confidence intervals (95%CI)=0.56-1.24 and 0.27-2.29; p=0.4205 and 0.8675, respectively]. Moreover, the presence of the variant T allele did not confer a modified risk of NPC (OR=0.84, 95%CI=0.60-1.19, p=0.3761). Intriguingly, a protective effect associated with the MMP-9 rs3918242 CT genotype against NPC risk was discerned among individuals abstaining from betel quid chewing behaviour (OR=0.51, 95%CI=0.30-0.87, p=0.0166). Notably, no significant association was established between the MMP-9 rs3918242 CT or TT genotype and NPC risk among individuals with or without smoking or alcohol consumption habits. Conclusion: Presence of the variant CT or TT genotype at MMP-9 rs3918242 did not appear to substantially contribute to an elevated risk of NPC. Notably, a protective effect against NPC risk was observed in individuals carrying the CT genotype, particularly in those abstaining from betel quid chewing. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Survival outcomes and toxicity profiles among patients with nonmetastatic nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy (IMRT) versus IMRT + carbon‐ion radiotherapy: A propensity score‐matched analysis.
- Author
-
Li, Yujiao, Guan, Xiyin, Xing, Xing, and Hu, Chaosu
- Subjects
INTENSITY modulated radiotherapy ,NASOPHARYNX cancer ,SURVIVAL rate ,OSTEORADIONECROSIS ,POISONS ,PROPENSITY score matching - Abstract
Objectives: To compare survival outcomes and toxic effects among patients with newly diagnosed nonmetastatic nasopharyngeal carcinoma (NPC) when treated with intensity‐modulated radiotherapy (IMRT) versus IMRT + carbon‐ion radiotherapy (CIRT). Methods: We performed a retrospective propensity score matching analysis (1:1) of patients treated with IMRT and IMRT + CIRT. Descriptive statistics were used to examine the baseline characteristics of the patients. Survival was estimated using the Kaplan–Meier method. Univariate and multivariable logistic regression analysis were used to identify the independent predictors of survival. We examined the association between risk factors and adverse events (AEs) using chi‐square tests. Cox model and logistic regression were used to analyze AEs. Results: Hundred and nine patients who received IMRT + CIRT were included and the median follow‐up time was 20.6 months (range: 4.6–82 months). There were no statistically significant differences in locoregional failure–free survival, distant metastasis–free survival, disease‐free survival, or overall survival between the two groups, but potentially better in IMRT + CIRT group (p > 0.05, respectively). Nodal boost was the only significant factor associated with LRFS and DFS on multivariable analysis. Thirty‐seven patients (34.0%) developed grade 3 acute OMs and no grade 4 acute OMs were observed in IMRT + CIRT group. All patients in IMRT + CIRT group developed grade 1 dermatitis; while in the match group, 76 patients developed grade 1 dermatitis, 27 patients developed grade 2 dermatitis, 5 patients developed grade 3 dermatitis, 1 patient developed grade 4 dermatitis. IMRT + CIRT treatment was associated with a significant trend of lower grades of OM and dermatitis (p < 0.05, respectively). Any severe (i.e., grade 3) chronic AEs, such as xerostomia, skin fibrosis, temporal lobe necrosis, osteoradionecrosis, or radiation‐induced optic neuropathy, was not observed. Conclusions: In this study, IMRT + CIRT was associated with significantly reduced acute toxicity burden compared with full course of IMRT, with excellent survival outcomes. Patients with persistent disease after treatment and treated with nodal boost had a worse outcome. More accurate assessments of IMRT + CIRT to primary nonmetastatic NPC patients will be imperative. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.